Investors

Company Profile

Altimmune is a clinical stage immunotherapeutics biotechnology company located in Montgomery County, MD with an additional operating site in London, UK. By leveraging the complementary attributes of its two innovative vaccine delivery platforms, RespirVec™ and Densigen™, Altimmune is able to design and develop immunotherapeutic products tailored to address a wide range of disease indications including acute respiratory infections, chronic viral infections, and cancer, with the potential for fundamental advantages over competing products.

2017 IRS Form 8937

Email alerts

Automatically receive Altimmune, Inc. financial information by e-mail

Subscribe